Mitchell S Levine Insider Trading $OCX OncoCyte Corp
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mitchell S Levine.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mitchell S Levine. Mitchell S Levine is CFO in OncoCyte Corp ($OCX) and Chief Financial Officer in OncoCyte Corp ($OCX).
Mitchell S Levine in OncoCyte Corp
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Mitchell S Levine: CFO, Chief Financial Officer
Holdings: 66,700 shares
Current Value: $363,515
Latest Transaction: Apr 30 2021
$OCX Market Capitalization: $159.33M
$OCX Previous Close: $5.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Mitchell S Levine in OncoCyte Corp
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30 2021 | OCX | OncoCyte Corp | Levine Mitchell S | Chief Financial Off ... | Option Exercise | M | 0.00 | 20,000 | 0 | 0 | |
| Apr 30 2021 | OCX | OncoCyte Corp | Levine Mitchell S | Chief Financial Off ... | Payment of Exercise | F | 0.00 | 4,620 | 0 | 62,080 | 66.7 K to 62.1 K (-6.93 %) |
| Apr 30 2021 | OCX | OncoCyte Corp | Levine Mitchell S | Chief Financial Off ... | Buy | M | 0.00 | 20,000 | 0 | 66,700 | 46.7 K to 66.7 K (+42.83 %) |
| Dec 15 2020 | OCX | OncoCyte Corp | Levine Mitchell S | CFO | Grant | A | 0.00 | 10,121 | 0 | 46,700 | 36.6 K to 46.7 K (+27.67 %) |
| Aug 04 2020 | OCX | OncoCyte Corp | Levine Mitchell S | Chief Financial Off ... | Buy | P | 1.32 | 10,000 | 13,200 | 36,579 | 26.6 K to 36.6 K (+37.62 %) |
| Apr 30 2020 | OCX | OncoCyte Corp | Levine Mitchell S | Chief Financial Off ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
| Apr 20 2020 | OCX | OncoCyte Corp | Levine Mitchell S | Chief Financial Off ... | Option Exercise | M | 0.00 | 20,000 | 0 | 0 | |
| Apr 20 2020 | OCX | OncoCyte Corp | Levine Mitchell S | Chief Financial Off ... | Payment of Exercise | F | 0.00 | 6,916 | 0 | 26,579 | 33.5 K to 26.6 K (-20.65 %) |
| Apr 20 2020 | OCX | OncoCyte Corp | Levine Mitchell S | Chief Financial Off ... | Buy | M | 0.00 | 20,000 | 0 | 33,495 | 13.5 K to 33.5 K (+148.20 %) |
| Feb 12 2020 | OCX | Oncocyte Corp | Levine Mitchell S | Chief Financial Off ... | Option Exercise | A | 2.63 | 204,000 | 536,520 | 204,000 | |
| Sep 12 2019 | OCX | OncoCyte Corp | Levine Mitchell S | Chief Financial Off ... | Buy | P | 2.01 | 10,000 | 20,060 | 10,000 | 0 to 10 K |
| Mar 18 2019 | OCX | OncoCyte Corp | Levine Mitchell S | Chief Financial Off ... | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
| Mar 18 2019 | OCX | OncoCyte Corp | Levine Mitchell S | Chief Financial Off ... | Option Exercise | A | 3.52 | 245,000 | 862,400 | 245,000 | |
| Jul 31 2018 | OCX | OncoCyte Corp | Levine Mitchell S | Chief Financial Off ... | Option Exercise | P | 3.00 | 3,495 | 10,485 | 3,495 | |
| Jul 31 2018 | OCX | OncoCyte Corp | Levine Mitchell S | Chief Financial Off ... | Buy | P | 0.00 | 3,495 | 0 | 3,495 | 0 to 3.5 K |
| Jul 31 2018 | OCX | OncoCyte Corp | Levine Mitchell S | Chief Financial Off ... | Option Exercise | P | 3.00 | 3,495 | 10,485 | 3,495 | |
| Jul 31 2018 | OCX | OncoCyte Corp | Levine Mitchell S | Chief Financial Off ... | Buy | P | 0.00 | 3,495 | 0 | 3,495 | 0 to 3.5 K |
| Jun 15 2018 | OCX | OncoCyte Corp | Levine Mitchell S | Chief Financial Off ... | Option Exercise | A | 2.55 | 45,000 | 114,750 | 45,000 | |
| Jun 01 2018 | OCX | OncoCyte Corp | Levine Mitchell S | Chief Financial Off ... | Option Exercise | A | 2.35 | 125,000 | 293,750 | 125,000 | |
| Jun 01 2018 | OCX | OncoCyte Corp | Levine Mitchell S | Chief Financial Off ... | Option Exercise | A | 2.35 | 125,000 | 293,750 | 125,000 | |
| Jun 01 2018 | OCX | OncoCyte Corp | Levine Mitchell S | Chief Financial Off ... | Option Exercise | A | 2.35 | 50,000 | 117,500 | 50,000 | |
| Jun 01 2018 | OCX | OncoCyte Corp | Levine Mitchell S | Chief Financial Off ... | Option Exercise | A | 2.35 | 50,000 | 117,500 | 50,000 | |
| Nov 17 2017 | OCX | OncoCyte Corp | Levine Mitchell S | Chief Financial Off ... | Option Exercise | A | 5.90 | 200,000 | 1,180,000 | 200,000 |
Page: 1